skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: Academic Search Premier (EB_SDU_P3) remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Leukemic Stem Cells: A Review
Leukemic Stem Cells: A Review
Material Type:
Artigo 		Adicionar ao Meu Espaço

Leukemic Stem Cells: A Review

O'Brien, J. A. ; Rizzieri, D. A.

Cancer investigation, 2013-05, Vol.31 (4), p.215-220 [Periódico revisado por pares]

New York, NY: Informa Healthcare

Texto completo disponível

Citações Citado por
2
CD52 Expression in Mantle Cell Lymphoma
CD52 Expression in Mantle Cell Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

CD52 Expression in Mantle Cell Lymphoma

Bass, Adam J. ; Gong, Jerald ; Nelson, Ramona ; Rizzieri, David A.

Leukemia & lymphoma, 2002, Vol.43 (2), p.339-342 [Periódico revisado por pares]

United States: Informa UK Ltd

Texto completo disponível

Citações Citado por
3
Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortality
Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortality
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortality

Maung, Ko ; Ramalingam, Sendhilnathan ; Chaudhry, Mohammad ; Ren, Yi ; Jung, Sin-Ho ; Romero, Kristi ; Corbet, Kelly ; Chao, Nelson J ; Choi, Taewoong ; Diehl, Anna Mae ; Diehl, Louis ; Gasparetto, Cristina ; Horwitz, Mitchell ; Long, Gwynn Douglas ; Lopez, Richard D ; Rizzieri, David A ; Sarantopoulos, Stefanie ; Sullivan, Keith M ; Bashir, Mustafa R ; Sung, Anthony D Alpini, Gianfranco D.

PloS one, 2020-09, Vol.15 (9), p.e0238824-e0238824 [Periódico revisado por pares]

San Francisco: Public Library of Science

Texto completo disponível

Citações Citado por
4
Anti proliferative activity of ELACYTac (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells
Anti proliferative activity of ELACYTac (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

Anti proliferative activity of ELACYTac (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells

Adams, David J ; Sandvold, Marit L ; Myhren, Finn ; Jacobsen, Tove F ; Giles, Frank ; Rizzieri, David A

Leukemia & lymphoma, 2008-04, Vol.49 (4), p.786-797 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
5
Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells
Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells

Adams, David J ; Sandvold, Marit L ; Myhren, Finn ; Jacobsen, Tove F ; Giles, Frank ; Rizzieri, David A

Leukemia & lymphoma, 2008-04, Vol.49 (4), p.786 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
6
Pulmonary sarcoidosis following stem cell transplantation: Is it more than a chance occurrence?
Pulmonary sarcoidosis following stem cell transplantation: Is it more than a chance occurrence?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pulmonary sarcoidosis following stem cell transplantation: Is it more than a chance occurrence?

BHAGAT, Rajesh ; RIZZIERI, David A ; VREDENBURGH, James J ; CHAO, Nelson J ; FOLZ, Rodney J

Chest, 2004-08, Vol.126 (2), p.642-644 [Periódico revisado por pares]

Northbrook, IL: American College of Chest Physicians

Texto completo disponível

Citações Citado por
7
Phase I evaluation of gemcitabine, mitoxantrone, and their effect on plasma disposition of fludarabine in patients with relapsed or refractory acute myeloid leukemia
Phase I evaluation of gemcitabine, mitoxantrone, and their effect on plasma disposition of fludarabine in patients with relapsed or refractory acute myeloid leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase I evaluation of gemcitabine, mitoxantrone, and their effect on plasma disposition of fludarabine in patients with relapsed or refractory acute myeloid leukemia

Rao, Arati V. ; Younis, Islam R. ; Sand, Gregory J. ; Spasojevic, Ivan ; Adams, David J. ; Decastro, Carlos M. ; Gockerman, John P. ; Peterson, Bercedis L. ; Petros, William P. ; Moore, Joseph O. ; Rizzieri, David A.

Leukemia & lymphoma, 2008-01, Vol.49 (8), p.1523-1529 [Periódico revisado por pares]

United States: Informa UK Ltd

Texto completo disponível

Citações Citado por
8
Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis
Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis

KHOURY, H. J ; KUKREJA, M ; GALE, R. P ; MARKS, D. I ; MCCARTHY, P. L ; WOOLFREY, A ; SZER, J ; GIRALT, S. A ; MAZIARZ, R. T ; CORTES, J ; HOROWITZ, M. M ; LEE, S. J ; GOLDMAN, J. M ; WANG, T ; HALTER, J ; ARORA, M ; GUPTA, V ; RIZZIERI, D. A ; GEORGE, B ; KEATING, A

Bone marrow transplantation (Basingstoke), 2012-06, Vol.47 (6), p.810-816 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
9
How to make the problem of divine hiddenness worse
How to make the problem of divine hiddenness worse
Material Type:
Artigo 		Adicionar ao Meu Espaço

How to make the problem of divine hiddenness worse

Rizzieri, Aaron

International journal for philosophy of religion, 2021-08, Vol.90 (1), p.3-17 [Periódico revisado por pares]

Dordrecht: Springer Netherlands

Texto completo disponível

Citações Citado por
10
Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment
Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment

KANDA, J ; KAYNAR, L ; GASPARETTO, C ; CHUTE, J. P ; MORRIS, A ; WINKEL, S ; MCPHERSON, J ; KURTZBERG, J ; CHAO, N. J ; HORWITZ, M. E ; KANDA, Y ; PRASAD, V. K ; PARIKH, S. H ; LAN, L ; SHEN, T ; RIZZIERI, D. A ; LONG, G. D ; SULLIVAN, K. M

Bone marrow transplantation (Basingstoke), 2013-07, Vol.48 (7), p.926-931 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (647)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (650)
  2. Reports  (4)
  3. magazinearticle  (3)
  4. Resenhas  (2)
  5. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1998  (6)
  2. 1998Até2003  (52)
  3. 2004Até2009  (172)
  4. 2010Até2016  (261)
  5. Após 2016  (169)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (656)
  2. Japonês  (81)
  3. Espanhol  (3)
  4. Português  (2)
  5. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.